<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Microbiol</journal-id><journal-id journal-id-type="publisher-id">bjm</journal-id><journal-title-group><journal-title>Brazilian Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1517-8382</issn><issn pub-type="epub">1678-4405</issn><publisher><publisher-name>Sociedade Brasileira de Microbiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26273265</article-id><article-id pub-id-type="pmc">4507542</article-id><article-id pub-id-type="doi">10.1590/S1517-838246246220140174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medical Microbiology</subject></subj-group></article-categories><title-group><article-title>KPC-2-producing <italic>Klebsiella pneumonia</italic>e in a hospital
in the Midwest region of Brazil</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Biberg</surname><given-names>Camila Arguelo</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref rid="c01" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Rodrigues</surname><given-names>Ana Claudia Souza</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>do Carmo</surname><given-names>Sidiane Ferreira</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Chaves</surname><given-names>Claudia Elizabeth Volpe</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Gales</surname><given-names>Ana Cristina</given-names></name><xref ref-type="aff" rid="aff04">4</xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Marilene Rodrigues</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib></contrib-group><aff id="aff01"><label>1</label>Universidade Federal de Mato Grosso do
Sul, Laborat&#x000f3;rio de Pesquisas
Microbiol&#x000f3;gicas, Universidade Federal de Mato Grosso do
Sul, Campo Grande, MS, Brasil, Laborat&#x000f3;rio de Pesquisas Microbiol&#x000f3;gicas,
Universidade Federal de Mato Grosso do Sul, Campo Grande, MS,
Brazil.</aff><aff id="aff02"><label>2</label>Hospital Regional de Mato Grosso do
Sul, Campo Grande, MS, Brasil, Laborat&#x000f3;rio de Microbiologia do Hospital
Regional Rosa Pedrossian de Mato Grosso do Sul, Campo Grande, MS,
Brazil.</aff><aff id="aff03"><label>3</label>Hospital Regional de Mato Grosso do
Sul, Campo Grande, MS, Brasil, Comiss&#x000e3;o de Controle de Infec&#x000e7;&#x000e3;o Hospitalar,
Hospital Regional Rosa Pedrossian de Mato Grosso do Sul, Campo Grande, MS,
Brazil.</aff><aff id="aff04"><label>4</label>Universidade Federal de S&#x000e3;o
Paulo, Laborat&#x000f3;rio Alerta, Divis&#x000e3;o de Doen&#x000e7;as Infecciosas, Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brasil, Laborat&#x000f3;rio Alerta, Divis&#x000e3;o de Doen&#x000e7;as
Infecciosas, Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP,
Brazil</aff><author-notes><corresp id="c01">Send correspondence to C.A. Biberg. Laborat&#x000f3;rio de Pesquisas
Microbiol&#x000f3;gicas, Universidade Federal de Mato Grosso do Sul, Rua Maria Izabel C.
Pontes 441, Bairro Nossa Sra. das Gra&#x000e7;as, 79116-060 Campo Grande, MS, Brazil.
E-mail: <email>cabiberg@hotmail.com</email>.</corresp><fn id="fn01" fn-type="other"><p>Associate Editor: Roxane Maria Fontes Piazza</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>46</volume><issue>2</issue><fpage>501</fpage><lpage>504</lpage><history><date date-type="received"><day>21</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>07</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Sociedade Brasileira de
Microbiologia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>All the content of the journal, except where otherwise noted, is
licensed under a Creative Commons License CC BY-NC.</license-p></license></permissions><abstract><p>The emergence of &#x003b2;-lactamase-producing <italic>Enterobacteriaceae</italic> in the
last few decades has become major challenge faced by hospitals. In this study,
isolates of <italic>Klebsiella pneumoniae</italic> carbapenemase-2
(KPC-2)-producing <italic>K. pneumoniae</italic> from a tertiary hospital in
Mato Grosso do Sul, Brazil, were characterized. Bacterial identification was
performed by matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF; Bruker Daltonics, Germany) mass spectrometry. The minimum inhibitory
concentrations of carbapenems were determined using the agar dilution method as
recommended by the Clinical Laboratory Standards Institute guidelines.
Carbapenemase production was detected using the modified Hodge test (MHT) and
polymerase chain reaction (PCR), followed by DNA sequencing. Of 360 (12.2%)
<italic>K. pneumoniae</italic> isolates obtained between May 2009 and May
2010, 44 (12.2%) were carbapenem nonsusceptible. Of these 44 isolates,
thirty-six <italic>K. pneumoniae</italic> isolates that were positive by MHT and
PCR carried the <italic>bla</italic>
<italic><sub>KPC-2</sub></italic> gene.
Thus, KPC-2producing <italic>Klebsiella pneumonia</italic>e has been present in
a Brazilian hospital located in the Midwest region since at least 2009.</p></abstract><kwd-group><kwd><italic>Klebsiella pneumoniae</italic></kwd><kwd>carbapenems</kwd><kwd>drug-resistant bacteria</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="14"/><page-count count="4"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The increasing prevalence of bacterial resistance among
<italic>Enterobacteriaceae</italic> isolated in hospitals is a global concern.
The major mechanism of carbapenem resistance among these bacteria is the production
of &#x003b2;-lactamase enzymes, including <italic>Klebsiella pneumoniae</italic>
carbapenemase (KPC).</p><p>KPC-type enzymes inactivate &#x003b2;-lactam antibiotics, including cephalosporins,
monobactams, and carbapenems, complicating the treatment of infections caused by
these bacteria (<xref rid="B08" ref-type="bibr">Hirsch and Tam, 2010</xref>).
KPC-2-producing <italic>Enterobacteriaceae</italic> have been isolated in many
Brazilian medical centers, most frequently in teaching hospitals in the southern and
southeastern regions. No data regarding the epidemiology of KPC strains in hospitals
in the Brazilian Midwest are available (<xref rid="B12" ref-type="bibr">Nicoletti
<italic>et al.</italic>, 2012</xref>).</p><p>The aim of this study was to investigate the presence of the
<italic>bla</italic>
<italic><sub>KPC</sub></italic> gene in
<italic>Klebsiella</italic> spp. carbapenem-nonsusceptible isolates collected
from a tertiary hospital in Mato Grosso do Sul, a Brazilian state in the Midwest
region.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Bacterial isolates</title><p>
<italic>Klebsiella</italic> spp. isolates that were nonsusceptible to imipenem,
meropenem, and/or ertapenem were collected from hospitalized patients at the
Regional Hospital of Mato Grosso do Sul (RHMS) between May 2009 and May 2010.
The bacterial isolates were recovered from urine, blood, surgical wound
exudates, catheter tips, tracheal aspirates and spinal cerebrospinal fluid
samples. Surveillance cultures were not included. Microbiology lab-books and
patient medical records were consulted to obtain demographic and clinical
data.</p></sec><sec><title>Identification and antimicrobial susceptibility</title><p>The <italic>Klebsiella</italic> spp. isolates were initially identified using
conventional biochemical reactions at the RHMS clinical laboratory. Bacterial
identification was confirmed by matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry using the Microflex LT System and
analysis by Biotyper 2.0 software (Bruker Daltonics, Germany) at the
Universidade Federal de S&#x000e3;o Paulo. The minimum inhibitory concentrations (MICs)
of carbapenems were determined using the agar dilution method as recommended by
the Clinical Laboratory Standards Institute (CLSI) guidelines (<xref rid="B05" ref-type="bibr">CLSI, 2011</xref>).</p></sec><sec><title>Carbapenemase production</title><p>The modified Hodge test (MHT) with ertapenem and imipenem disks (10 &#x003bc;g each) was
employed for the phenotypic detection of carbapenemase production (<xref rid="B05" ref-type="bibr">CLSI, 2011</xref>). A molecular investigation of
the <italic>bla</italic>
<italic><sub>KPC</sub></italic> gene was performed with
all <italic>K. pneumoniae</italic> carbapenem nonsusceptible (resistant or
intermediate) isolates.</p><p>DNA extraction, PCR and sequencing of the PCR products were performed according
to <xref rid="B09" ref-type="bibr">Monteiro (2009)</xref> with minor
modifications. DNA extraction was made by boiling method. One or two colonies
were transferred to a microcentrifuge tube containing 300 &#x003bc;L of sterile MilliQ
water. The suspension was boiled for 5 min and subsequently centrifuged for 1
min at 12,000 rpm. The supernatant was carefully aspirated and transferred to a
new sterile microtube.</p><p>The following primers were used to amplify the bla<sub>KPC</sub> gene: forward,
5&#x02032; TCGCTAAACTCGAACAGG 3&#x02032; and reverse, 5&#x02032; TTACTGCCCGTTGACGCCCAATCC 3&#x02032;.</p></sec><sec><title>PCR reaction</title><p>A master mix solution containing 1.0 &#x003bc;L of each primer (10 &#x003bc;mol), 12.5 &#x003bc;L of Go
Taq &#x000ae; Green Master Mix 2&#x000d7; (Promega, Madison, USA) and 8.5 &#x003bc;L of sterile MilliQ
water was prepared. Then, 2 &#x003bc;L of DNA was added to achieve a final reaction
volume of 25 &#x003bc;L. The reactions were amplified in an Eppendorf AG System,
Eppendorf Mastercycler (Hamburg, Germany).</p><p>The cycling parameters were as follows: 10 min at 94 &#x000b0;C, followed by 35 cycles of
denaturation at 94 &#x000b0;C for 1 min, annealing at 52 &#x000b0;C for 1 min, and extension at
72 &#x000b0;C for 1 min. The PCR amplification was completed with a final extension
cycle at 72 &#x000b0;C for 10 min.</p><p>The PCR products were sequenced after purification using a QIA quick Gel
Extraction kit (Qiagen, Hilden, Alemanha) as described by the manufacturer. The
amplified genomic DNA was quantified by optical density in a spectrophotometer
(NanoDrop&#x000ae; ND-1000 UV-Vis, version 3.2.1; Thermo Fisher Scientific, Wilmington,
DE, USA). Approximately 70 ng of DNA was prepared for sequencing using the Big
Dye Terminator Cycle Sequencing (Applied Biosystems, Foster City, USA) kit.
Sequencing was performed on an ABI PRISM 3130 Genetic Analyzer (Applied
Biosystems, Foster City, USA).</p><p>The resulting DNA sequences and their corresponding protein sequences were
analyzed using the Lasergene Software Package (DNASTAR, Madison, WI) and
compared with genetic databases available on the Internet (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/fasta33/">http://www.ebi.ac.uk/fasta33/</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST/">http://www.ncbi.nlm.nih.gov/BLAST/</ext-link>).</p><p>This study was approved by the Research Ethics Committee of the Federal
University of Mato Grosso do Sul.</p></sec></sec><sec sec-type="results"><title>Results</title><p>During the study period, 360 isolates of <italic>Klebsiella</italic> spp. were
identified by the RHMS clinical laboratory, of which 44 (12.2%) were nonsusceptible
to carbapenems according to the CLSI breakpoints (<xref rid="B05" ref-type="bibr">CLSI, 2011</xref>). Identification as <italic>Klebsiella pneumoniae</italic>
was confirmed by MALDI-TOF for all isolates. The antimicrobial susceptibility
testing results for the carbapenems are reported in <xref rid="t01" ref-type="table">Table 1</xref>. Thirty-six of the forty-four carbapenem-nonsusceptible
<italic>K. pneumoniae</italic> isolates were phenotypic carbapenemase producers
as determined by the MHT, and all of those 36 isolates carried the
<italic>bla</italic>
<italic><sub>KPC-2</sub></italic> gene.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>
<italic>In vitro</italic> antimicrobial activity of carbapenems against 44
<italic>K. pneumoniae</italic> isolates.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Antimicrobial agent</th><th colspan="2" valign="bottom" align="center" rowspan="1">MIC (mg/L)</th><th colspan="2" valign="bottom" align="center" rowspan="1">% by Category<xref rid="TFN01" ref-type="table-fn">1</xref>
</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="2" valign="bottom" align="left" rowspan="1">
<hr/>
</th><th colspan="2" valign="bottom" align="left" rowspan="1">
<hr/>
</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">50%</th><th valign="bottom" align="center" rowspan="1" colspan="1">90%</th><th valign="bottom" align="center" rowspan="1" colspan="1">Susceptible</th><th valign="bottom" align="center" rowspan="1" colspan="1">Nonsusceptible</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Ertapenem</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">32</td><td valign="top" align="center" rowspan="1" colspan="1">6.8</td><td valign="top" align="center" rowspan="1" colspan="1">93.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Meropenem</td><td valign="top" align="center" rowspan="1" colspan="1">0.5</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">79.5</td><td valign="top" align="center" rowspan="1" colspan="1">20.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Imipenem</td><td valign="top" align="center" rowspan="1" colspan="1">0.5</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">84.1</td><td valign="top" align="center" rowspan="1" colspan="1">15.9</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><label>1</label><p>Breakpoint criteria established by the CLSI document (<xref rid="B05" ref-type="bibr">CLSI, 2011</xref>).</p></fn></table-wrap-foot></table-wrap><p>The PCR amplification profile of the
<italic>bla</italic>
<italic><sub>KPC</sub></italic> gene (800 bp) from the
<italic>K. pneumoniae</italic> isolates is shown in <xref rid="f01" ref-type="fig">Figure 1</xref>
<italic>.</italic>
</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>PCR amplification profile of the
<italic>bla</italic>
<italic><sub>KPC</sub></italic> gene (800 bp)
from the <italic>K.</italic> pneumoniae isolates. M: 100 bp DNA ladder
marker. Samples 2, 4, 9, 7, 10, 11, 12, 15, 17, 22, 23, 24, 25, 28, 31, 32,
34, 40, 47, and 49: <italic>K.</italic> pneumoniae clinical
isolates<italic>.</italic> Sample 7 was negative for the presence of the
<italic>bla</italic>
<italic><sub>KPC</sub></italic> gene.</title></caption><graphic xlink:href="1517-8382-bjm-46-2-501-gf01"/></fig><p>Patients infected with KPC-producing <italic>K. pneumoniae</italic> were primarily
admitted to the intensive care unit (ICU) (43%), followed by the internal medicine
department and coronary care unit (13.6% each, respectively). The age of the
patients ranged from 0 to 91 years, with a median age of 68 years. Of the 44
patients included in this study, 43.2% died. KPC-producing <italic>K.
pneumoniae</italic> (36) was most frequently isolated from urine (41.7%), blood
cultures (25%), surgical wound exudates (22.3%), catheter tips (5.5%) and tracheal
aspirates (5.5%).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The prevalence of carbapenem-resistant Enterobacteriaceae has increased substantially
during the last decade (<xref rid="B03" ref-type="bibr">Castanheira <italic>et
al.</italic>, 2012</xref>; <xref rid="B13" ref-type="bibr">Nordmann
<italic>et al.</italic>, 2011</xref>). The rapid increase and dissemination
of carbapenemases, such as KPC, is a major challenge for clinical laboratories and
physicians. The identification of the bacterial mechanisms of resistance is critical
for infection control and epidemiological studies. However, molecular biology
techniques for the detection of resistance genes are not yet available in most
Brazilian routine laboratories.</p><p>In this study, we detected the presence of KPC-2-producing <italic>K.</italic>
pneumoniae. This subtype is one of the most frequently occurring worldwide (<xref rid="B11" ref-type="bibr">Nadkarni <italic>et al.</italic>, 2009</xref>; <xref rid="B13" ref-type="bibr">Nordmann <italic>et al.</italic>, 2011</xref>), and
the prevalence of this subtype in other Brazilian regions has been described
previously (<xref rid="B03" ref-type="bibr">Castanheira <italic>et al.</italic>,
2012</xref>; <xref rid="B10" ref-type="bibr">Monteiro <italic>et al.</italic>,
2009</xref>; <xref rid="B12" ref-type="bibr">Nicoletti <italic>et al.</italic>,
2012</xref>). KPC-producing <italic>K.</italic> pneumoniae in Brazil was first
described in 2006 by <xref rid="B09" ref-type="bibr">Monteiro <italic>et
al.</italic> (2009)</xref> in a patient from the state of Pernambuco. An
increasing number of cases were subsequently reported in geographically distant
Brazilian cities, indicating the wide dissemination of KPC-2-producing isolates in
Brazil (<xref rid="B03" ref-type="bibr">Castanheira <italic>et al.</italic>,
2012</xref>; <xref rid="B12" ref-type="bibr">Nicoletti <italic>et al.</italic>,
2012</xref>).</p><p>As shown in <xref rid="t01" ref-type="table">Table 1</xref>, resistance to ertapenem
(MIC &#x02265; 1) was more frequent (93%) than resistance to imipenem (16%). These findings
are in agreement with data reported by the Centers for Disease Control and
Prevention (CDC) indicating that ertapenem resistance is the best marker for
carbapenemase production (<xref rid="B04" ref-type="bibr">CDC, 2012</xref>). The MHT
demonstrated accurate results, with 100% sensitivity and 100% specificity, compared
with PCR, corroborating a study by <xref rid="B07" ref-type="bibr">Fehlberg
<italic>et al.</italic> (2012)</xref>.</p><p>In our study, eight <italic>K. pneumoniae</italic> isolates were KPC negative,
suggesting the involvement of other resistance mechanisms. Carbapenem resistance may
involve multiple mechanisms, such as production of carbapenemases (KPC, NDM, OXA,
and M&#x003b2;L) alone or in combination with the loss of porins (<xref rid="B06" ref-type="bibr">Doumith <italic>et al.</italic>, 2009</xref>.), ESBL (TEM, SHV,
CTX-M) and/or AmpC enzymes associated with porin loss, and the presence of efflux
pumps (<xref rid="B02" ref-type="bibr">Carvalhaes <italic>et al.</italic>,
2009</xref>; <xref rid="B07" ref-type="bibr">Fehlberg <italic>et al.</italic>,
2012</xref>, <xref rid="B14" ref-type="bibr">Queenam <italic>et al.</italic>,
2007</xref>).</p><p>The high number of patients over 60 years of age (65.9%) and the high frequency of
ICU admissions (43%) suggests that colonization by these multi-resistant bacteria is
favored by the high number of invasive procedures and the prolonged use of
broad-spectrum antibiotics associated with these units (<xref rid="B01" ref-type="bibr">Beir&#x000e3;o <italic>et al.</italic>, 2011</xref>; <xref rid="B13" ref-type="bibr">Nordmann <italic>et al.</italic>, 2011</xref>).</p><p>A rapid and effective method for detecting KPC-producing <italic>K.
pneumoniae</italic> is needed to avoid therapeutic failures and introduce
measures to prevent and control the dissemination of these multi-resistant
microorganisms (<xref rid="B08" ref-type="bibr">Hirsch and Tam, 2010</xref>).</p><p>Notably, 38.6% of the KPC-producing <italic>K. pneumoniae</italic> isolates were
detected in urine cultures, and 31.8% were detected in blood cultures. These data
confirm literature findings that <italic>Klebsiella</italic> spp. is an important
causative agent of urinary tract infections in hospitalized patients (<xref rid="B01" ref-type="bibr">Beir&#x000e3;o <italic>et al.</italic>, 2011</xref>).</p><p>Finally, we conclude that this study provides evidence of the presence of <italic>K.
pneumoniae</italic> isolates carrying the <italic>bla</italic>
<sub>KPC-2</sub>
gene in a Brazilian hospital located in the Midwest region since at least 2009. The
results presented in this study further support the dissemination of this pathogen
throughout the national territory. Understanding the mechanisms underlying
resistance may facilitate the implementation of preventive measures, control of the
dissemination of these pathogens, and the implementation of surveillance programs
and effective therapies.</p></sec></body><back><ref-list><title>References</title><ref id="B01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beir&#x000e3;o</surname><given-names>EM</given-names></name><name><surname>Furtado</surname><given-names>JJD</given-names></name><name><surname>Girardello</surname><given-names>R</given-names></name><etal/></person-group><year>2011</year><article-title>Clinical and microbiological characterization of KPC-producing
<italic>Klebsiella pneumoniae</italic> infections in
Brazil</article-title><source>Braz J Infect Dis</source><volume>15</volume><fpage>69</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">21412593</pub-id></element-citation></ref><ref id="B02"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalhaes</surname><given-names>CG</given-names></name><name><surname>Pic&#x000e3;o</surname><given-names>RC</given-names></name><name><surname>Nicoletti</surname><given-names>AG</given-names></name><etal/></person-group><year>2009</year><article-title>Cloverleaf test (modified Hodge test) for detecting carbapenemase
production in <italic>Klebsiella pneumoniae</italic>: be aware of false
positive results</article-title><source>J Antimicrob Chemother</source><volume>65</volume><fpage>1</fpage><lpage>3</lpage></element-citation></ref><ref id="B03"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castanheira</surname><given-names>M</given-names></name><name><surname>Costello</surname><given-names>AJ</given-names></name><name><surname>Deshpande</surname><given-names>LM</given-names></name><etal/></person-group><year>2012</year><article-title>Expansion of Clonal Complex 258 KPC-2-Producing
<italic>Klebsiella pneumoniae</italic> in Latin American Hospitals:
Report of the SENTRY Antimicrobial Surveillance Program</article-title><source>Antimicrob Agents Chemother</source><volume>56</volume><fpage>1668</fpage><lpage>1669</lpage><pub-id pub-id-type="pmid">22337899</pub-id></element-citation></ref><ref id="B04"><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Centers for Diseases Control and Prevention (CDC)</collab></person-group><year>2012</year><source>Department of health and human services centers for disease control and
prevention</source><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/maso/FACM/pdfs/HICPAC/2008061213_HICPAC_Minutes.pdf">http://www.cdc.gov/maso/FACM/pdfs/HICPAC/2008061213_HICPAC_Minutes.pdf</ext-link></comment><date-in-citation>Accessed 22 May 2012</date-in-citation></element-citation></ref><ref id="B05"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Clinical and Laboratory Standards Institute</collab></person-group><year>2011</year><chapter-title>Performance Standards for Antimicrobial Susceptibility
Testing</chapter-title><source>Twenty-First Informational Supplement. M100-S21</source><volume>30</volume><issue>1</issue><publisher-name>Clinical and Laboratory Standards Institute</publisher-name><publisher-loc>Wayne, PA</publisher-loc></element-citation></ref><ref id="B06"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doumith</surname><given-names>M</given-names></name><name><surname>Ellington</surname><given-names>MJ</given-names></name><name><surname>Livermore</surname><given-names>DM</given-names></name><etal/></person-group><year>2009</year><article-title>Molecular mechanisms disrupting porin expression in ertapenem-
resistant Klebsiella and Enterobacter spp. clinical isolates from the
UK</article-title><source>J Antimicrob Chemother</source><volume>63</volume><fpage>659</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">19233898</pub-id></element-citation></ref><ref id="B07"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehlberg</surname><given-names>LCC</given-names></name><name><surname>Carvalho</surname><given-names>AMC</given-names></name><name><surname>Campana</surname><given-names>EH</given-names></name><etal/></person-group><year>2012</year><article-title>Emergence of <italic>Klebsiella pneumoniae</italic>-producing
KPC-2 carbapenemase in Para&#x000ed;ba, Northeastern Brazil</article-title><source>Braz J Infect Dis</source><volume>16</volume><fpage>577</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">23158264</pub-id></element-citation></ref><ref id="B08"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>EB</given-names></name><name><surname>Tam</surname><given-names>VH</given-names></name></person-group><year>2010</year><article-title>Detection and treatment options for <italic>Klebsiella
pneumoniae</italic> carbapenemases (KPCs): an emerging cause of
multidrug-resistant infection</article-title><source>J Antimicrob Chemother</source><volume>65</volume><fpage>1119</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">20378670</pub-id></element-citation></ref><ref id="B09"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>J</given-names></name></person-group><year>2009</year><source>Caracteriza&#x000e7;&#x000e3;o molecular dos mecanismos de resist&#x000ea;ncia aos antibi&#x000f3;ticos
&#x003b2;-lact&#x000e2;micos em <italic>Klebsiella</italic> spp. isoladas de infec&#x000e7;&#x000f5;es de
corrente sangu&#x000ed;nea do Projeto SCOPE Brasil</source><comment>Tese de Doutorado</comment><publisher-name>Universidade Federal de S&#x000e3;o Paulo</publisher-name><publisher-loc>S&#x000e3;o Paulo</publisher-loc><size units="pages">145</size></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>J</given-names></name><name><surname>Santos</surname><given-names>AF</given-names></name><name><surname>Asensi</surname><given-names>MD</given-names></name><etal/></person-group><year>2009</year><article-title>First Report of KPC-2-Producing <italic>Klebsiella pneumonia
s</italic>trains in Brazil</article-title><source>Antimicrob Agents Chemother</source><volume>53</volume><fpage>333</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">19015350</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadkarni</surname><given-names>AB</given-names></name><name><surname>Schliep</surname><given-names>T</given-names></name><name><surname>Khan</surname><given-names>L</given-names></name><etal/></person-group><year>2009</year><article-title>Cluster of bloodstream infections caused by KPC-2
carbapenemase-producing <italic>Klebsiella pneumoniae</italic> in
Manhattan</article-title><source>Am J Infect Control</source><volume>37</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">19249638</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>AG</given-names></name><name><surname>Fehlberg</surname><given-names>LCC</given-names></name><name><surname>Pic&#x000e3;o</surname><given-names>RC</given-names></name></person-group><person-group person-group-type="author"><collab>American J Infect Control</collab></person-group><year>2012</year><article-title>Clonal complex 258, the most frequently found multilocus sequence
type complex in KPC-2-producing <italic>Klebsiella pneumoniae</italic>
isolated in Brazilian hospitals</article-title><source>Antimicrob Agents Chemother</source><volume>56</volume><fpage>4563</fpage><lpage>4564</lpage><pub-id pub-id-type="pmid">22826287</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>T</given-names></name><name><surname>Naas</surname><given-names>T</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name></person-group><year>2011</year><article-title>Global spread of carbapenemase- producing
Enterobacteriaceae</article-title><source>Emerg Infect Dis</source><volume>17</volume><fpage>1791</fpage><lpage>1797</lpage><pub-id pub-id-type="pmid">22000347</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queenan</surname><given-names>AM</given-names></name><name><surname>Bush</surname><given-names>K</given-names></name></person-group><year>2007</year><article-title>Carbapenemases: the versatile beta-lactamases</article-title><source>Clin Microbiol Rev</source><volume>20</volume><fpage>440</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">17630334</pub-id></element-citation></ref></ref-list></back></article>